祥生医疗：12月12日召开董事会会议

Group 1 - The core viewpoint of the article highlights that Xiangsheng Medical (SH 688358) announced its board meeting to discuss the profit distribution plan for the first three quarters of 2025 [1] - For the year 2024, the revenue composition of Xiangsheng Medical is reported to be 99.88% from the medical device industry and 0.12% from other businesses [1] - As of the report, the market capitalization of Xiangsheng Medical stands at 3.3 billion yuan [1]